Macrolide-resistant Mycoplasma pneumoniae in humans, Ontario, Canada, 2010-2011.
Macrolide-resistant Mycoplasma pneumoniae in humans, Ontario, Canada, 2010-2011.
复制标题
DOI：
10.3201/eid1909.121466
复制
发表时间：
2013
影响因子：
11.8
通讯作者：
Patel SN
中科院分区：
文献类型：
--
作者：
Eshaghi A;Memari N;Tang P;Olsha R;Farrell DJ;Low DE;Gubbay JB;Patel SN
肺炎支原体的抗菌药物耐药率是根据 2011 年至 2012 年在加拿大安大略省获得的临床标本和分离株确定的。在91个肺炎支原体耐药样本中，11个（12.1%）在23S rRNA基因中携带与大环内酯类耐药相关的核苷酸突变。肺炎支原体标本均未对氟喹诺酮类药物或四环素类药物产生耐药性。
Antimicrobial drug resistance rates for Mycoplasma pneumoniae was determined in clinical specimens and isolates obtained during 2011–2012 in Ontario, Canada. Of 91 M. pneumoniae drug-resistant specimens, 11 (12.1%) carried nucleotide mutations associated with macrolide resistance in the 23S rRNA gene. None of the M. pneumoniae specimens were resistant to fluoroquinolones or tetracyclines.